UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2014
Commission File Number 001-33042
ROSETTA GENOMICS LTD.
(Translation of registrant’s name into English)
10 Plaut Street, Science Park |
Rehovot 76706, Israel |
(Address of Principal Executive Offices) |
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F [Ö ] Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Rosetta Genomics Ltd.
The Board of Directors of Rosetta Genomics Ltd. (the “Company”) has determined to cancel the previously scheduled annual general meeting of shareholders that was scheduled to be held on Friday, October 10, 2014, due to discussions with third parties that may affect certain proposals that were to be brought before the shareholders at the meeting. Once these discussions are concluded, the Company will reschedule the annual general meeting and redistribute a new proxy statement and new proxy cards to its shareholders.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ROSETTA GENOMICS LTD. | ||
Date: September 16, 2014 | By: | /s/ Oded Biran |
Oded Biran | ||
C.L.O. and Secretary |